BioMarin Pharmaceutical Price to Free Cash Flow Ratio 2010-2024 | BMRN

BioMarin Pharmaceutical current price to free cash flow ratio as of November 21, 2024 is 37.41.

  • BioMarin Pharmaceutical average price to free cash flow ratio for 2023 was 73.81, a 55% decline from 2022.
  • BioMarin Pharmaceutical average price to free cash flow ratio for 2022 was 164.01, a 42.97% decline from 2021.
  • BioMarin Pharmaceutical average price to free cash flow ratio for 2021 was 114.72, a 18.81% increase from 2020.

Price to free cash flow ratio can be defined as

BioMarin Pharmaceutical Price to Free Cash Flow Ratio 2010-2024 | BMRN

  • BioMarin Pharmaceutical average price to free cash flow ratio for 2023 was 73.81, a 55% decline from 2022.
  • BioMarin Pharmaceutical average price to free cash flow ratio for 2022 was 164.01, a 42.97% decline from 2021.
  • BioMarin Pharmaceutical average price to free cash flow ratio for 2021 was 114.72, a 18.81% increase from 2020.

Price to free cash flow ratio can be defined as